OBJECTIVE: To analyze genetically based impairment in histamine-metabolising enzymes in patients with Parkinson's disease (PD). METHODS: Leukocytary DNA from 214 PD patients and a control group of 295 unrelated healthy individuals was studied for nonsynonymous histamine N-methyltransferase (HNMT) and diamine oxidase (ABP1) polymorphisms by using amplification-restriction analyses. RESULTS: An association of the HNMT Thr105Ile polymorphism, but not of the ABP1 His645Asp polymorphism, with PD was observed. Patients with PD showed a higher frequency of homozygous HNMT genotypes leading to high activity with a gene-dose effect (P < 0.001), as compared to healthy subjects. These findings were independent of gender, but the association with the HNMT polymorphism is higher among patients with late-onset PD (P < 0.0001). CONCLUSION: These results, combined with previous findings indicating alterations in histamine levels in patients with PD, suggest that alterations of histamine homeostasis in the SNC are associated with the risk for PD.
OBJECTIVE: To analyze genetically based impairment in histamine-metabolising enzymes in patients with Parkinson's disease (PD). METHODS: Leukocytary DNA from 214 PDpatients and a control group of 295 unrelated healthy individuals was studied for nonsynonymous histamine N-methyltransferase (HNMT) and diamine oxidase (ABP1) polymorphisms by using amplification-restriction analyses. RESULTS: An association of the HNMT Thr105Ile polymorphism, but not of the ABP1 His645Asp polymorphism, with PD was observed. Patients with PD showed a higher frequency of homozygous HNMT genotypes leading to high activity with a gene-dose effect (P < 0.001), as compared to healthy subjects. These findings were independent of gender, but the association with the HNMT polymorphism is higher among patients with late-onset PD (P < 0.0001). CONCLUSION: These results, combined with previous findings indicating alterations in histamine levels in patients with PD, suggest that alterations of histamine homeostasis in the SNC are associated with the risk for PD.
Authors: Matthew J Farrer; Kristoffer Haugarvoll; Owen A Ross; Jeremy T Stone; Nicole M Milkovic; Stephanie A Cobb; Andrew J Whittle; Sarah J Lincoln; Mary M Hulihan; Michael G Heckman; Linda R White; Jan O Aasly; J Mark Gibson; David Gosal; Timothy Lynch; Zbigniew K Wszolek; Ryan J Uitti; Mathias Toft Journal: Am J Hum Genet Date: 2006-06 Impact factor: 11.025
Authors: H Matsumine; M Saito; S Shimoda-Matsubayashi; H Tanaka; A Ishikawa; Y Nakagawa-Hattori; M Yokochi; T Kobayashi; S Igarashi; H Takano; K Sanpei; R Koike; H Mori; T Kondo; Y Mizutani; A A Schäffer; Y Yamamura; S Nakamura; S Kuzuhara; S Tsuji; Y Mizuno Journal: Am J Hum Genet Date: 1997-03 Impact factor: 11.025
Authors: C M van Duijn; M C Dekker; V Bonifati; R J Galjaard; J J Houwing-Duistermaat; P J Snijders; L Testers; G J Breedveld; M Horstink; L A Sandkuijl; J C van Swieten; B A Oostra; P Heutink Journal: Am J Hum Genet Date: 2001-07-02 Impact factor: 11.025
Authors: Alexis Elbaz; Lorene M Nelson; Haydeh Payami; John P A Ioannidis; Brian K Fiske; Grazia Annesi; Andrea Carmine Belin; Stewart A Factor; Carlo Ferrarese; Georgios M Hadjigeorgiou; Donald S Higgins; Hideshi Kawakami; Rejko Krüger; Karen S Marder; Richard P Mayeux; George D Mellick; John G Nutt; Beate Ritz; Ali Samii; Caroline M Tanner; Christine Van Broeckhoven; Stephen K Van Den Eeden; Karin Wirdefeldt; Cyrus P Zabetian; Marie Dehem; Jennifer S Montimurro; Audrey Southwick; Richard M Myers; Thomas A Trikalinos Journal: Lancet Neurol Date: 2006-11 Impact factor: 44.182
Authors: Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink Journal: Science Date: 2002-11-21 Impact factor: 47.728
Authors: Jiaojiao Li; Chunxiao Sun; Wenwen Cai; Jing Li; Barry P Rosen; Jian Chen Journal: Mutat Res Rev Mutat Res Date: 2021-10-07 Impact factor: 7.015
Authors: Brett H Keeling; Carles Vilariño-Güell; Alexandra I Soto-Ortolaza; Owen A Ross; Ryan J Uitti; Alex Rajput; Zbigniew K Wszolek; Matthew J Farrer Journal: Parkinsonism Relat Disord Date: 2009-09-20 Impact factor: 4.891
Authors: Maria C Ledesma; Elena García-Martín; Hortensia Alonso-Navarro; Carmen Martínez; Félix Javier Jiménez-Jiménez; Julián Benito-León; Inmaculada Puertas; Lluisa Rubio; Tomás López-Alburquerque; José A G Agúndez Journal: Neuromolecular Med Date: 2008-06-10 Impact factor: 3.843
Authors: Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez Journal: Medicine (Baltimore) Date: 2016-07 Impact factor: 1.889
Authors: Pedro Ayuso; Carmen Martínez; Pau Pastor; Oswaldo Lorenzo-Betancor; Antonio Luengo; Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; José A G Agúndez; Elena García-Martín Journal: Front Cell Neurosci Date: 2014-09-24 Impact factor: 5.505